BioPharma Credit PLC. Stock Analysis BPCR.L

BioPharma Credit PLC is a GB-based company operating in Capital Markets industry. The company employs 15 full-time employees The company went IPO on 2017-03-27. BioPharma Credit PLC is a United Kingdom-based closed-ended investment company. The firm is a specialist debt investor in the life sciences industry. The firm seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products. The firm may also invest in equity issued by a life sciences company, acquired directly from the life sciences company or in the secondary market. The company will seek to create a diversified portfolio of investments by investing across a range of different forms of debt assets issued by a variety of borrowers. The company has two wholly owned subsidiaries: BPCR Limited Partnership and BPCR GP Limited. The firm holds a majority of its investments through its financing subsidiary, BPCR Limited Partnership.